Back to Search
SUSAN URBA, MD
MD
Medical Oncology Physician
NPI: 1447336318Individual
Specialties, Licenses & Credentials
Hospice and Palliative Medicine (Internal Medicine) Physician
Internal Medicine — Hospice and Palliative Medicine
Code: 207RH0002X
4301048137(MI)
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
4301048137(MI)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
4301048137(MI)
Research & Publications (20)
Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.
PMID 16380415·J Clin Oncol·2006
3-trial
Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial.
PMID 15625363·J Clin Oncol·2005
3-trial
Gemcitabine and cisplatin for patients with metastatic or recurrent esophageal carcinoma: a Southwest Oncology Group Study.
PMID 14707499·Invest New Drugs·2004
3-trial
Concurrent cisplatin, paclitaxel, and radiotherapy as preoperative treatment for patients with locoregional esophageal carcinoma.
PMID 14601087·Cancer·2003
3-trial
Combined modality therapy of esophageal cancer--standard of care?
PMID 12424857·Surg Oncol Clin N Am·2002
6-review
Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma.
PMID 11208820·J Clin Oncol·2001
3-trial
Neoadjuvant therapy for organ preservation in head and neck cancer.
PMID 11129024·Laryngoscope·2000
3-trial
Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II trial (S0216).
PMID 19557750·Head Neck·2010
3-trial
Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion.
PMID 19504552·Laryngoscope·2009
4-observational
Antiemesis. Clinical Practice Guidelines in Oncology.
PMID 19460282·J Natl Compr Canc Netw·2009
6-review
NCCN clinical practice guidelines in oncology: palliative care.
PMID 19406043·J Natl Compr Canc Netw·2009
6-review
Advanced squamous cell carcinoma of the oropharynx: efficacy of positron emission tomography and computed tomography for determining primary tumor response during induction chemotherapy.
PMID 19189338·Head Neck·2009
3-trial
Long-term results of a phase III randomized trial of postoperative radiotherapy with or without carboplatin in patients with high-risk head and neck cancer.
PMID 18091334·Laryngoscope·2008
3-trial
Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number.
PMID 18474879·J Clin Oncol·2008
8-other
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer.
PMID 18474878·J Clin Oncol·2008
8-other
Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking.
PMID 17848274·Int J Radiat Oncol Biol Phys·2007
8-other
Targeting apoptosis to overcome cisplatin resistance: a translational study in head and neck cancer.
PMID 17848273·Int J Radiat Oncol Biol Phys·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1500 E MEDICAL CENTER DR
ANN ARBOR, MI 48109 - Phone
- (734) 936-4000
Quick Facts
- NPI
- 1447336318
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile